Aclidinium Other names: Aclidinium bromide

Chemical formula: C₂₆H₃₀BrNO₄S₂  Molecular mass: 484.651 g/mol  PubChem compound: 11434515

Therapeutic indications

Aclidinium is indicated for:

Chronic obstructive pulmonary disease

Population group: only adults (18 years old or older)

Aclidinium bromide is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.